Stay updated on Incyte Press Releases
Sign up to get notified when there's something new on the Incyte Press Releases page.

Latest updates to the Incyte Press Releases page
- Check2 days agoChange DetectedTwo new May 2026 press releases were added to the list (TRuE-AD4 data for Opzelura and inducement grants). Two older March 2026 items were removed, changing the set of items displayed on the Press Releases page.SummaryDifference5%

- Check9 days agoChange DetectedNew entries appear on the press releases page for May 2026, including the FDA approval of Jakafi XR and the appointment of Suketu Upadhyay as CFO, along with other first-quarter updates. Older items have been removed from the current listing, shifting which releases are shown on the first page.SummaryDifference5%

- Check17 days agoChange DetectedThe press releases listing has been updated to show a different page of results, including the pagination controls and the release entry shown on the current page (notably the “Incyte Highlights New Phase 3 Tafasitamab Data” item for April 21, 2026). One previously listed press release (January 5, 2026) is no longer included in the displayed set for this page view.SummaryDifference2%

- Check31 days agoChange DetectedA new press release titled 'Incyte to Report First Quarter Financial Results' dated April 9, 2026 has been added to the press releases list.SummaryDifference0.5%

- Check38 days agoChange DetectedAdded a new press release entry dated March 28, 2026: 'Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting'.SummaryDifference0.5%

- Check46 days agoChange DetectedA new press release entry titled 'Incyte Announces Executive Leadership Appointments' dated March 25, 2026 was added to the Press Releases page.SummaryDifference0.5%

Stay in the know with updates to Incyte Press Releases
Enter your email address, and we'll notify you when there's something new on the Incyte Press Releases page.